Roche's Tecentriq nabbed key approvals in breast cancer and small-cell lung cancer last month.  Roche’s Tecentriq has scored some important victories lately, inc...

A Pfizer vaccine candidate meant to protect against 20 different strains of pneumococcal disease was well-tolerated, safe and elicited an immune response in a Phase ...

Clovis Oncology's shares have fallen by roughly 15% since the biotech disclosed the halting of a Phase 2 study of Rubraca in recurrent, metastatic bladder cancer....

An experimental gene therapy for hemophilia A helped to restore activity of an essential blood-clotting protein in several patients with the blood disorder, boost...

This comes as United Therapeutics has been doing a series of pacts and buyouts amid generic competition. (Bryan Brandenburg/CC by-SA 3.0) United Therapeutics is ...

Merrimack Pharmaceuticals is shelving yet another lead candidate after a review of Phase 1 safety data found the drug wasn't going to meet an "optimal therapeutic in...